Xenogeneic subcutaneous tumor model experiments showed that combined vemurafenib and Ref-1 inhibitor treatment significantly inhibited the growth and progression of xenogeneic subcutaneous tumors (Fig. 7A). The gene discussed is APEX1; the disease is neoplasm.